{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:09:29Z","timestamp":1780668569153,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.suronc.2026.102442","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:18:42Z","timestamp":1777576722000},"page":"102442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Axillary dissection vs. non-axillary dissection in breast cancer patients with sentinel lymph node metastasis: An updated systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8077-1187","authenticated-orcid":false,"given":"Paulo Eduardo Souza","family":"Castelo Branco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Mauricio Costa","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriane Helena Silva","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Prates","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda Tereza Neiva","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Hellen Sousa","family":"Matias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane de S\u00e1 Lopes","family":"Lomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-6654","authenticated-orcid":false,"given":"Eduardo Batista","family":"C\u00e2ndido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.suronc.2026.102442_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0149-7944(02)00777-8","article-title":"History of surgery for breast cancer: radical to the sublime","volume":"60","author":"Cotlar","year":"2003","journal-title":"Curr. Surg."},{"issue":"5","key":"10.1016\/j.suronc.2026.102442_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00000658-189407000-00075","article-title":"The results of operations for the cure of cancer of the breast performed at the Johns Hopkins hospital from June, 1889, to January, 1894","volume":"20","author":"Halsted","year":"1894","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.suronc.2026.102442_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.suronc.2026.102442_bib4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/cncr.22847","article-title":"Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection","volume":"110","author":"Hwang","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.suronc.2026.102442_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10434-004-1164-2","article-title":"Axillary recurrence after sentinel node biopsy","volume":"12","author":"Jeruss","year":"2005","journal-title":"Ann. Surg Oncol."},{"issue":"18","key":"10.1016\/j.suronc.2026.102442_bib6","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1200\/JCO.2008.19.5750","article-title":"Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer","volume":"27","author":"Bilimoria","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2026.102442_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American college of surgeons oncology group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.suronc.2026.102442_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.suronc.2026.102442_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/tbj.14191","article-title":"Changes in utilization of axillary dissection in women with invasive breast cancer and sentinel node metastasis after the ACOSOG Z0011 trial","volume":"27","author":"Tseng","year":"2021","journal-title":"Breast J."},{"issue":"10","key":"10.1016\/j.suronc.2026.102442_bib10","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1245\/s10434-016-5310-4","article-title":"A population-based study of the effects of a regional guideline for completion axillary lymph node dissection on axillary surgery in patients with breast cancer","volume":"23","author":"Tsao","year":"2016","journal-title":"Ann. Surg Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2026.102442_bib11","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/SLA.0000000000002440","article-title":"Trends on axillary surgery in nondistant metastatic breast cancer patients treated between 2011 and 2015: a Dutch population-based study in the ACOSOG-Z0011 and AMAROS era","volume":"268","author":"Poodt","year":"2018","journal-title":"Ann. Surg."},{"issue":"30","key":"10.1016\/j.suronc.2026.102442_bib12","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2026.102442_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.6004\/jnccn.2009.0012","article-title":"Breast cancer. Clinical practice guidelines in oncology","volume":"7","author":"Carlson","year":"2009","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"13","key":"10.1016\/j.suronc.2026.102442_bib14","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update","volume":"32","author":"Lyman","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2026.102442_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update","volume":"35","author":"Lyman","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.suronc.2026.102442_bib16","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1200\/JCO-25-00099","article-title":"Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update","volume":"43","author":"Park","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.suronc.2026.102442_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijsu.2016.08.022","article-title":"Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: a systematic review and meta-analysis of randomized controlled trials using the GRADE system","volume":"34","author":"Huang","year":"2016","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.suronc.2026.102442_bib19","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"issue":"71","key":"10.1016\/j.suronc.2026.102442_bib20","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br. Med. J."},{"issue":"3","key":"10.1016\/j.suronc.2026.102442_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12282-015-0588-9","article-title":"Histological examination of sentinel lymph nodes: significance of macrometastasis, micrometastasis, and isolated tumor cells","volume":"22","author":"Tsuda","year":"2015","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.suronc.2026.102442_bib22","article-title":"RoB 2: a revised tool for assessing risk of bias in andomized trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7650","key":"10.1016\/j.suronc.2026.102442_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.suronc.2026.102442_bib24","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American college of surgeons oncology group trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2026.102442_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann. Surg."},{"issue":"10","key":"10.1016\/j.suronc.2026.102442_bib26","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs No axillary dissection on 10-Year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"32","key":"10.1016\/j.suronc.2026.102442_bib27","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (alliance) trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102442_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sol\u00e1","year":"2013","journal-title":"Ann. Surg Oncol."},{"issue":"12","key":"10.1016\/j.suronc.2026.102442_bib29","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a andomized, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.suronc.2026.102442_bib30","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2026.102442_bib31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla \u2013 surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"S\u00e1volt","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2026.102442_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial [published correction appears in lancet Oncol. 2013 Jun;14(7):e254]","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.suronc.2026.102442_bib33","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a andomized, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol."},{"issue":"13","key":"10.1016\/j.suronc.2026.102442_bib34","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.suronc.2026.102442_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","article-title":"Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial","volume":"17","author":"de Boniface","year":"2017","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.suronc.2026.102442_bib36","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1245\/s10434-022-11866-w","article-title":"Preservation of axillary lymph nodes compared with complete dissection in T1-2 breast cancer patients presenting one or two metastatic sentinel lymph nodes: the SINODAR-ONE multicenter randomized clinical trial","volume":"29","author":"Tinterri","year":"2022","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2026.102442_bib37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.breast.2016.06.016","article-title":"SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes","volume":"30","author":"Tinterri","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.suronc.2026.102442_bib38","article-title":"Patient-reported outcomes for the intergroup sentinel mamma study (INSEMA): a andomized trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer","volume":"55","author":"Reimer","year":"2022","journal-title":"EclinicalMedicine"},{"issue":"15","key":"10.1016\/j.suronc.2026.102442_bib39","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","article-title":"Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system","volume":"25","author":"Hudis","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102442_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12893-023-02101-8","article-title":"Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis","volume":"23","author":"Fan","year":"2023","journal-title":"BMC Surg."},{"issue":"8","key":"10.1016\/j.suronc.2026.102442_bib41","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ejso.2015.05.007","article-title":"Axillary lymph node dissection versus sentinel lymph node biopsy alone for early breast cancer with sentinel node metastasis: a meta-analysis","volume":"41","author":"Li","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2026.102442_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.suronc.2026.102442_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.suronc.2026.102442_bib44","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1200\/JCO.2005.03.228","article-title":"Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial","volume":"23","author":"Purushotham","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2026.102442_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results of the ALMANAC andomized trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.suronc.2026.102442_bib46","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12885-015-1613-2","article-title":"The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)","volume":"15","author":"van Roozendaal","year":"2015","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.suronc.2026.102442_bib47","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.clon.2015.07.005","article-title":"POSNOC: a randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases","volume":"27","author":"Goyal","year":"2015","journal-title":"Clin. Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426000939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426000939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:06:54Z","timestamp":1780664814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740426000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"alternative-id":["S0960740426000939"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102442","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Axillary dissection vs. non-axillary dissection in breast cancer patients with sentinel lymph node metastasis: An updated systematic review and meta-analysis of randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102442"}}